Showing results (451-460 of 630) with videos related to
Sort By:
Pageof 63
Frontiers in Cardiovascular Medicine|May 16, 2022
Long-Term Clinical Outcomes Between Biodegradable and Durable Polymer Drug-Eluting Stents: A Nationwide Cohort StudySeung-Jun Lee, Dong-Woo Choi, Yongsung Suh, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 22, 2024
Targeting ROS-sensing Nrf2 potentiates anti-tumor immunity of intratumoral CD8+ T and CAR-T cellsYuna Jo, Ju A Shim, Jin Woo Jeong, et al.Circulation. Cardiovascular Interventions|November 3, 2016
Association Between Duration of Dual Antiplatelet Therapy and Angiographic Multivessel Disease on Outcomes in Patients Treated With Newer-Generation Drug-Eluting StentsSeung-Yul Lee, Myeong-Ki Hong, Dong-Ho Shin, et al.Clinical Therapeutics|August 12, 2011
Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertensionHae-Young Lee, Bum-Kee Hong, Wook Jin Chung, et al.Korean Circulation Journal|July 27, 2019
The Current Status of Percutaneous Coronary Intervention in Korea: Based on Year 2014 & 2016 Cohort of Korean Percutaneous Coronary Intervention (K-PCI) RegistryDong Ho Shin, Hyun Jae Kang, Jae Sik Jang, et al.Coronary Artery Disease|November 15, 2008
Significant association of coronary stent fracture with in-stent restenosis in sirolimus-eluting stentsJung-Sun Kim, Seung-Yul Lee, Jung Myung Lee, et al.Korean Circulation Journal|October 17, 2017
The Use Pattern and Clinical Impact of New Antiplatelet Agents Including Prasugrel and Ticagrelor on 30-day Outcomes after Acute Myocardial Infarction in Korea: Korean Health Insurance Review and Assessment DataChoongki Kim, Dong Ho Shin, Chul Min Ahn, et al.Circulation. Cardiovascular Interventions|June 12, 2020
Optical Coherence Tomography for Coronary Bioresorbable Vascular Scaffold Implantation: A Randomized Controlled TrialSeung-Yul Lee, Do-Yoon Kang, Sung-Jin Hong, et al.Biorxiv : the Preprint Server for Biology|September 26, 2025
Efineptakin alfa (NT-I7) improves overall survival and induces tertiary lymphoid structures in murine lung tumorsTrang Dinh, Judong Lee, Sidra Islam, et al.Diabetes, Obesity & Metabolism|November 23, 2023
Moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with metabolic syndrome and atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING trialYong-Joon Lee, Sang-Hyup Lee, Seng Chan You, et al.Pageof 63